Timothy Brears

The Wellcome Trust Ltd. engages welfare and charitable services. It supports the discovery of vaccines and drug-resistant infections, diversity and inclusion, open research, government investment in research, data sharing in public health emergencies, and strengthening ecosystems. The company was founded by Henry Wellcome in 1936 and is headquartered in London, UK.

Cogenics Icoria, Inc. provides medical research services. The firm offers genomics and proteomics-related research instruments, consumables, data, including databases, software & other research-oriented products. Icoria offers gene expression analysis and other related services. Its tissue informatics software performs tissue analysis for toxicology studies of early-stage drug candidates and other purposes. The firm also provides biomarkers to develop diagnostics and therapies for liver injuries, metabolic conditions & cancer. The company is headquartered in Research Triangle Park, NC.

ProterixBio, Inc. supplies novel protein measurement technology. It manufactures and markets the ViBE platform, enabling highly sensitive, automated acoustic immunoassays to accelerate drug discovery, development and production of biological and pharmaceutical products. The company was founded by Edward F. Crawley and Mark Lundstrom in 2002 and is headquartered in Billerica, MA.

Parallax Diagnostics, Inc. provides diagnostic testing systems and solutions. It develops bio-medical products, diagnostic and monitoring platforms in the area of infectious diseases. The company was founded on April 12, 2010 and is headquartered in Cambridge, MA.

Molten Ventures (Private Equity) (Molten Ventures) is a venture capital firm subsidiary of Molten Ventures Plc founded in 1998 by Simon Christopher Cook and Stuart Malcolm Chapman. The firm is headquartered in London, United Kingdom.

Cancer Research UK provides cancer research services. It supports and undertakes research on the biology and causes of cancer and develops anti-cancer drugs. The firm also provides general information about cancer and types of treatments and funds projects that help patients cope with the side effects of cancer and its treatment. Its institute also operates an online portal CancerHelp UK that provides patient information. The company was founded in 2001 and is headquartered in London, the United Kingdom.

Part of Sarepta Therapeutics, Inc., Ercole Biotech, Inc. develops splice switching drugs for the treatment of major human diseases. The company is based in Research Triangle Park, NC. The company was founded by Jorn Gorlach. Ercole Biotech was acquired by Sarepta Therapeutics, Inc. on March 20, 2008 for $8.25 million.

Psynova Neurotech Ltd. provides commercial development and exploitation of novel biomarkers for Neuropsychiatric and other mental illnesses. The company was founded by Sabine Bahn on August 1, 2005 and is headquartered in Cambridge, the United Kingdom.

Endomagnetics Ltd. develops surgical instruments used in the treatment of cancer. It offers SentiMag, a surgical instrument for use in the treatment of breast cancer and melanoma by helping surgeons to identify the sentinel lymph node for excision and subsequent histology to determine whether cancer has spread from a nearby tumor site. The company was founded by Quentin Pankhurst, Simon Hattersley, and Audrius Brazdeikis in April 2007 and is headquartered in Cambridge, the United Kingdom.

Ieso Digital Health Ltd. provides Internet enabled mental health services to health providers, private individuals and businesses. The firm engages in delivering cognitive behavioral therapy. It offers anxiety, bereavement, child and family, depression, drug and alcohol misuse, eating disorder, managing anger, managing pain, obsessive compulsive disorder, panic, phobia, post traumatic stress, relationship, sexual difficulty, sports psychology, stress management, and terminal illness therapy services. The company was founded by Barnaby Perks, Sue Wright and Nadine Field in 2000 and is headquartered in Cambridge, the United Kingdom.

Fluidic Analytics Ltd. develops proprietary technology to characterize proteins. The company was founded by Tuomas Knowles in 2013 and is headquartered in Cambridge, the United Kingdom.

EcoEos, Inc. provides environmental genetic testing services. The company is based in San Francisco, CA. The company was founded by Gregory Stock, David Ewing Duncan, Lisa A. Conte. Gregory Stock has been the CEO since incorporation.

Oxford Science Enterprises PLC (Oxford Science Enterprises) is a venture capital firm founded in 2015. The firm is headquartered in Oxford, United Kingdom.

Push Dr. Ltd. provides NHS-commissioned online service connecting patients with a network. The company was founded in 2013 by Eren Ozagir and is headquartered West Midlands, the United Kingdom.

Lifesum AB operates a platform that helps make better food choices and improve exercise and reach health goals. Its application combines technology and applied psychology with personal preferences. The company was founded by Tove Westlund, Martin Wahlby, Henrik Torstensson and Marcus Gners in 2008 and is headquartered in Stockholm, Sweden.

Mimi Hearing Technologies GmbH engages in the development of hearing enhancement technology and tools for smart phones. It offers Mimi.io, an application that allows users to perform hearing test, try different hearing enhancement profiles, and experience the difficulties associated with hearing loss. The company was founded by Nick Clark, Philipp Skribanowitz, and Pascal Werner in 2014 and is headquartered in Berlin, Germany.

Kheiron Medical Technologies Ltd. develops learning powered tools to help radiologists, radiology departments, imaging centers and hospitals. The company was founded by Peter Daniel Kecskemethy and Tobias Rijken in 2016 and is headquartered in London, the United Kingdom.

Pelago operates as a subset of digital health. It specializes in health discipline and treatment option that utilizes digital and often online health technologies to treat a medical or psychological condition. The company was founded by Yusuf Sherwani, Sarim Siddiqui and Maroof Ahmed in 2016 and is headquartered in London, the United Kingdom.

Closed Loop Medicine Ltd. operates as a new breed of therapeutics company focused on care pathways, outcomes and the provision of dynamic personalised regimens. It combines proven drugs with digital therapeutics enabling the digitisation and data capture of an entire care continuum. The company was founded by Felicity Sartain, Hakim Yadi, Paul Goldsmith, and David Cox in 2017 and is headquartered in London, the United Kingdom.

Arctoris Ltd. is a British tech-enabled biopharma platform company that combines robotics and machine learning with a world-class team for accelerated small molecule discovery. The company is based in Oxford, UK, with its operations also located in the same city. Arctoris' unique technology platform, Ulysses, enables the company and its partners to conduct their R&D significantly faster, with improved data quality and depth. Arctoris progresses a pipeline of wholly-owned and partnered first-in-class and best-in-class therapeutics in oncology and neurodegeneration. The company was founded in 2016 by Martin-Immanuel Bittner and Thomas A. Fleming, with Martin-Immanuel Bittner serving as the CEO since then.

Healthily By Your Md provides a self-care app designed to assist individuals in managing their health.

Zoe Ltd. is a British women-owned company that has been designing semi-custom party wear dresses for over 35 years. Zoe is based in London, UK. The company's design team works one-on-one with customers to create gorgeous gowns for any occasion. The company offers a collection of trendy dresses for girls aged 4 to 16, characterized by intricate designs with luxury fabrics. Customers can shop their collection online and purchase items directly from stores. Extra fabric and additional sizes are available upon request. The company was founded in 2017.

Horizon Discovery Ltd. develops and supplying patient-relevant drug discovery and diagnostic research tools. The frm also supplies genetically-defined cell lines, reporter gene assay kits, genomic reference standards and contract research services to organizations engaged in bio-pharmaceutical process optimization, drug discovery & development, and clinical diagnostic development. The company was founded by Christopher John Torrance and Alberto Bardelli on February 14, 2005 and is headquartered in Cambridge, the United Kingdom.